AMERICAN CENTURY COMPANIES INC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 748054
KANSAS CITY, MO
Position in ALNY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$558,096,374
-$38,251,471 QoQ
Shares Held
1,853,956
+2.9% QoQ
Ownership
1.39%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#18
of 784 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 7%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERICAN CENTURY COMPANIES INC holds $3,568,637,643 across 178 Biotechnology names. ALNY ranks #1 (15.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
1,853,956 | $558,096,374 | |
| 2 | ASND |
Ascendis Pharma A/S
|
1,400,575 | $373,561,364 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
580,901 | $288,550,953 | |
| 4 | ARGX |
Argenx SE
|
173,193 | $160,683,269 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
1,947,076 | $154,383,656 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,791,664 | $97,484,438 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,539,512 | $92,463,631 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
1,682,179 | $90,282,546 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $558,096,374 | 1,853,956 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $596,347,845 | 1,802,363 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $590,574,271 | 1,485,161 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $748,497,096 | 1,641,441 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $584,955,242 | 1,793,846 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $475,352,658 | 1,760,435 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $377,442,887 | 1,604,024 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $438,049,356 | 1,592,733 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $329,063,067 | 1,354,169 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $205,292,590 | 1,373,654 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $79,424,431 | 414,944 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $78,409,785 | 442,743 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $83,359,157 | 438,871 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $89,063,874 | 444,608 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $166,306,281 | 699,795 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $138,712,281 | 693,007 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $83,855,144 | 574,941 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $184,818,806 | 1,131,844 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $170,016,498 | 1,002,574 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $202,304,439 | 1,071,471 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $177,350,128 | 1,046,190 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $154,535,419 | 1,094,521 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $140,283,119 | 1,079,350 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $144,043,827 | 989,312 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $147,693,218 | 997,186 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $44,261,457 | 406,628 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||